170 related articles for article (PubMed ID: 11279081)
21. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.
Iwasaki M; Tanaka Y; Kobayashi H; Murata-Hirai K; Miyabe H; Sugie T; Toi M; Minato N
Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005
[TBL] [Abstract][Full Text] [Related]
22. Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
Sanders JM; Ghosh S; Chan JM; Meints G; Wang H; Raker AM; Song Y; Colantino A; Burzynska A; Kafarski P; Morita CT; Oldfield E
J Med Chem; 2004 Jan; 47(2):375-84. PubMed ID: 14711309
[TBL] [Abstract][Full Text] [Related]
23. DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.
Nussbaumer O; Gruenbacher G; Gander H; Thurnher M
Blood; 2011 Sep; 118(10):2743-51. PubMed ID: 21673342
[TBL] [Abstract][Full Text] [Related]
24. Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes.
Decaup E; Duault C; Bezombes C; Poupot M; Savina A; Olive D; Fournié JJ
Immunol Lett; 2014 Sep; 161(1):133-7. PubMed ID: 24925024
[TBL] [Abstract][Full Text] [Related]
25. Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.
Gu S; Borowska MT; Boughter CT; Adams EJ
Semin Cell Dev Biol; 2018 Dec; 84():65-74. PubMed ID: 29471037
[TBL] [Abstract][Full Text] [Related]
26. Human gamma delta T cells induce dendritic cell maturation.
Ismaili J; Olislagers V; Poupot R; Fournié JJ; Goldman M
Clin Immunol; 2002 Jun; 103(3 Pt 1):296-302. PubMed ID: 12173304
[TBL] [Abstract][Full Text] [Related]
27. Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
Favier B; Espinosa E; Tabiasco J; Dos Santos C; Bonneville M; Valitutti S; Fournié JJ
J Immunol; 2003 Nov; 171(10):5027-33. PubMed ID: 14607899
[TBL] [Abstract][Full Text] [Related]
28. Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens.
Kato Y; Tanaka Y; Miyagawa F; Yamashita S; Minato N
J Immunol; 2001 Nov; 167(9):5092-8. PubMed ID: 11673519
[TBL] [Abstract][Full Text] [Related]
29. Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses.
Kadri H; Taher TE; Xu Q; Sharif M; Ashby E; Bryan RT; Willcox BE; Mehellou Y
J Med Chem; 2020 Oct; 63(19):11258-11270. PubMed ID: 32930595
[TBL] [Abstract][Full Text] [Related]
30. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
Nussbaumer O; Gruenbacher G; Gander H; Komuczki J; Rahm A; Thurnher M
J Immunol; 2013 Aug; 191(3):1346-55. PubMed ID: 23794630
[TBL] [Abstract][Full Text] [Related]
31. Non-peptide antigens activating human Vgamma9/Vdelta2 T lymphocytes.
Poupot M; Fournié JJ
Immunol Lett; 2004 Sep; 95(2):129-38. PubMed ID: 15388252
[TBL] [Abstract][Full Text] [Related]
32. Human gamma delta T cells: Evolution and ligand recognition.
Adams EJ; Gu S; Luoma AM
Cell Immunol; 2015 Jul; 296(1):31-40. PubMed ID: 25991474
[TBL] [Abstract][Full Text] [Related]
33. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
[TBL] [Abstract][Full Text] [Related]
34. Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells.
Glatzel A; Wesch D; Schiemann F; Brandt E; Janssen O; Kabelitz D
J Immunol; 2002 May; 168(10):4920-9. PubMed ID: 11994442
[TBL] [Abstract][Full Text] [Related]
35. Small molecules for the activation of human gammadelta T cell responses against infection.
Kabelitz D
Recent Pat Antiinfect Drug Discov; 2008 Jan; 3(1):1-9. PubMed ID: 18221182
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the immune response of human cord-blood derived gamma/delta T cells to stimulation with aminobisphosphonate compounds.
Placido R; Auricchio G; Gabriele I; Galli E; Brunetti E; Colizzi V; Battistini L; Mancino G
Int J Immunopathol Pharmacol; 2011; 24(1):101-10. PubMed ID: 21496392
[TBL] [Abstract][Full Text] [Related]
37. Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.
Gossman W; Oldfield E
J Med Chem; 2002 Oct; 45(22):4868-74. PubMed ID: 12383012
[TBL] [Abstract][Full Text] [Related]
38. Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.
Kiladjian JJ; Visentin G; Viey E; Chevret S; Eclache V; Stirnemann J; Bourhis JH; Chouaib S; Fenaux P; Caignard A
Haematologica; 2008 Mar; 93(3):381-9. PubMed ID: 18268282
[TBL] [Abstract][Full Text] [Related]
39. Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators?
Riganti C; Massaia M; Davey MS; Eberl M
Eur J Immunol; 2012 Jul; 42(7):1668-76. PubMed ID: 22806069
[TBL] [Abstract][Full Text] [Related]
40. Differential activation of human gammadelta cells by nonpeptide phosphoantigens.
Sireci G; Espinosa E; Di Sano C; Dieli F; Fournié JJ; Salerno A
Eur J Immunol; 2001 May; 31(5):1628-35. PubMed ID: 11465120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
